<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879682</url>
  </required_header>
  <id_info>
    <org_study_id>5496/12</org_study_id>
    <nct_id>NCT02879682</nct_id>
  </id_info>
  <brief_title>nTMS for Motor Mapping of Rolandic Lesions</brief_title>
  <acronym>Motorstim</acronym>
  <official_title>Randomized Controlled Multicenter Trial on the Impact of Presurgical Navigated Transcranial Magnetic Stimulation for Motor Mapping of Rolandic Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Evangelisches Krankenhaus Bielefeld gGmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare presurgical motor mapping by navigated transcranial magnetic stimulation for
      surgery (nTMS) of rolandic lesions to surgery with mapping without implementing these data
      into neuronavigation as control.

      Primary objective: Permanently new postoperative deficit is lower when the preoperative motor
      mapping is available to the surgeon
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental intervention:

      presurgical motor mapping by navigated transcranial magnetic stimulation and fusion with
      intraoperative neuronavigation

      Control intervention:

      presurgical motor mapping by navigated transcranial magnetic stimulation without access of
      the surgeon to this data Follow-up per patient: 6 months Duration of intervention per
      patient: 45 minutes
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operation-related neurological motor deficit 3 months after surgery as measured by NIHSS scale</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>deterioration in NIHSS score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changed indication for surgery</measure>
    <time_frame>1 - 7 days before surgery</time_frame>
    <description>towards surgery, avoids surgery towards biopsy, avoids surgery towards follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of the approach</measure>
    <time_frame>1 - 7 days before surgery</time_frame>
    <description>using a different direct to approach the lesion (different sulcus, gyrus, sub cortically)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>size of craniotomy</measure>
    <time_frame>intraoperatively</time_frame>
    <description>in mm ap and lateral</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of intraoperative motor mapping via MEP</measure>
    <time_frame>intraoperatively</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of intraoperative motor mapping via MEP</measure>
    <time_frame>intraoperatively</time_frame>
    <description>in min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of surgery</measure>
    <time_frame>intraoperatively</time_frame>
    <description>in min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>extent of resection</measure>
    <time_frame>intraoperatively</time_frame>
    <description>in % via volumetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of further modalities (fMRI, DTI fiber tracking, SSEP phase reversal)</measure>
    <time_frame>intraoperatively</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Glioma</condition>
  <condition>Brain Metastases</condition>
  <arm_group>
    <arm_group_label>nTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>presurgical motor mapping by nTMS and fusion with intraoperative neuronavigation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-nTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>presurgical motor mapping by nTMS without access of the surgeon to these data</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nTMS data available for the surgeon</intervention_name>
    <description>the preoperatively acquired map of the motor cortex by nTMS will be available for the surgeon</description>
    <arm_group_label>nTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nTMS data not available for the surgeon</intervention_name>
    <description>the preoperatively acquired map of the motor cortex by nTMS will not be available for the surgeon</description>
    <arm_group_label>non-nTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key inclusion criteria:

          -  indication for resection of a supratentorial tumor within or adjacent to the primary
             motor cortex

          -  preoperative nTMS mapping of the ipsilateral hemisphere

          -  implementation of the mapping data into preoperative planning

          -  continuous MEP monitoring - informed consent

        Key exclusion criteria:

          -  no motor eloquent tumor

          -  infratentorial tumor

          -  no postoperative imaging

          -  prognosis lower than 3 months of survival - age &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandro M Krieg, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technische Universität München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandro M Krieg, MD, MBA</last_name>
    <phone>+498941409482</phone>
    <email>sandro.krieg@tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sebastian Ille, MD</last_name>
    <phone>+498941405693</phone>
    <email>sebastian.ille@tum.de</email>
  </overall_contact_backup>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2016</study_first_submitted>
  <study_first_submitted_qc>August 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>August 22, 2016</last_update_submitted>
  <last_update_submitted_qc>August 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glioma</keyword>
  <keyword>brain metastases</keyword>
  <keyword>nTMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

